Fortress Biotech Inc (FBIO) stock saw a decline, ending the day at $2.18 which represents a decrease of $-0.18 or -7.63% from the prior close of $2.36. The stock opened at $2.33 and touched a low of ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 6.11% of ...

Cassava Sciences Inc (SAVA) stock saw a decline, ending the day at $2.4 which represents a decrease of $-0.10 or -4.00% from the prior close of $2.5. The stock opened at $2.44 and touched a low of $2.

JMP Securities has recently initiated Prime Medicine Inc (PRME) stock to Mkt Outperform rating, as announced on December 10, 2024, according to Finviz. Earlier, on May 20, 2024, H.C. Wainwright had ...

Lattice Semiconductor Corp (LSCC) stock saw a decline, ending the day at $56.72 which represents a decrease of $-2.24 or -3.80% from the prior close of $58.96. The stock opened at $57.9 and touched a ...

On Monday, Cara Therapeutics Inc (CARA) stock saw a decline, ending the day at $0.35 which represents a decrease of $-0.03 or -7.89% from the prior close of $0.38. The stock opened at $0.37 and ...

On Monday, Anavex Life Sciences Corp (AVXL) stock saw a decline, ending the day at $11.04 which represents a decrease of $-1.07 or -8.84% from the prior close of $12.11. The stock opened at $11.91 and ...

Cognizant Technology Solutions Corp (CTSH) stock saw a decline, ending the day at $76.75 which represents a decrease of $-2.45 or -3.09% from the prior close of $79.2. The stock opened at $78.45 and ...

On Monday, Yeti Holdings Inc (YETI) stock saw a decline, ending the day at $38.64 which represents a decrease of $-0.71 or -1.80% from the prior close of $39.35. The stock opened at $38.93 and touched ...

Robert W. Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 27.82% ...

Kura Oncology Inc (KURA) stock saw a decline, ending the day at $8.51 which represents a decrease of $-0.16 or -1.85% from the prior close of $8.67. The stock opened at $8.65 and touched a low of ...